Group 1 | ||
---|---|---|
< 83.8% | ≥83.8% | |
Total | 119 | 120 |
Gender (Females / Males) | 54/65 | 66/54 |
Age at visit (y) | 21.6 ± 5.9 | 21.5 ± 6.4 |
Age at cancer diagnosis (y) | 6.2 ± 4.8 | 6.3 ± 4.4 |
Time from the end of the treatment (y) | 13.1 ± 5.1 | 12.8 ± 5.0 |
Weight (kg) | 67.4 ± 18.1 | 66.2 ± 14.6 |
Height (cm) | 166.1 ± 11.5 | 165.6 ± 8.3 |
\( \dot{\mathrm{V}} \)O2 peak (mL.kg−1.min−1) | 28.5 ± 6.2 | 35.8 ± 8.6* |
Power at \( \dot{\mathrm{V}} \) O2 peak (W) | 162.6 ± 55.2 | 185.6 ± 53.3* |
\( \dot{\mathrm{V}} \)O2 peak predicted (%) | 71.9 ± 10.0 | 98.0 ± 11.7* |
Physical activity (min) | 22.4 ± 29.6 | 32.9 ± 28.5* |